Eisbach Bio

Munich, Germany

Eisbach Bio is a biotechnology company that creates new drugs that target molecular vulnerabilities in cancer genomes.

$4.8M raised

Nov 2024

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Eisbach Bio raised?

Eisbach Bio has raised $4.8M in total funding. The most recent round was Grant. The last funding was announced in November 2024.

Who are Eisbach Bio's investors?

Eisbach Bio's investors include Cancer Prevention and Research Institute of Texas, Cancer Focus Fund, Pinto Ventures.

Where is Eisbach Bio headquartered?

Eisbach Bio is headquartered in Munich, Germany.

What does Eisbach Bio do?

Eisbach Bio is a biotechnology company that creates new drugs that target molecular vulnerabilities in cancer genomes.

What stage is Eisbach Bio at?

Eisbach Bio is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 26, 2024.

MLA

"Eisbach Bio — Funding & Investors." VCBacked, November 26, 2024, https://www.vcbacked.co/company/eisbach-bio. Accessed July 2, 2026.

APA

VCBacked. (2024). Eisbach Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/eisbach-bio

Wikipedia (cite web)

{{cite web |title=Eisbach Bio — Funding & Investors |url=https://www.vcbacked.co/company/eisbach-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 26, 2024.